Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-20

Clinical Trial Update: Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension [Phase 2]

View source ↗

Summary

This Phase 2 trial update from Bayer assesses the effects of Angeliq and Prempro on blood pressure and sodium sensitivity in postmenopausal women with prehypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANGELIQ (DROSPIRENONE AND ESTRADIOL)
  • PREMPRO (Conjugated estrogens and medroxyprogesterone acetate)

Snippet

Sponsor: Bayer | Conditions: Postmenopause, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2010-01-20